Kevin Rademakers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kevin Rademakers has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Gammie
Bristol Urological Institute Southmead Hospital Bristol UK
4 shared publications - Enrico Finazzi Agrò
Urology Unit, Department of Surgical Sciences, Tor Vergata University Hospital, University of Rome Tor Vergata, Rome, Italy
4 shared publications - Glenn Thomas Werneburg
Department of Urology, University of Michigan, Ann Arbor, Michigan
3 shared publications - Gommert A. van Koeveringe
Department of Urology Maastricht University Maastricht The Netherlands
3 shared publications - Paul Abrams
Bristol Urological Institute, Southmead Hospital Bristol UK
3 shared publications Sachin Malde
Department of Urology Guy's and St Thomas' NHS Foundation Trust London UK
3 shared publications
Latest Publications
- Open Access
- 13 January 2026
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 18 (1) , e70046
Genitourinary Toxicity, Function, and Quality of Life in Patients Undergoing Prostate Radiation Therapy—A Scoping Review
The effects of prostate radiotherapy (external beam radiation therapy (EBRT) and brachytherapy (BRT)) on urinary adverse events (UAEs), lower urinary tract function, and quality of life were examined in this scoping review. PubMed, Cochrane, and Embase (OVID) were used to identify relevant articles. We discuss the results of 23 studies. Included studies showed that UAEs are common after prostate radiation therapy. Across modalities, approximately one third experience acute events (Grade ≥ 2 median 36% for both EBRT and BRT), while one quarter experience late events (Grade ≥ 2 median 20% for EBRT and 26% for BRT). These estimates vary by UAE grading definitions and study designs. In the long term, patients with mild lower urinary tract symptoms (LUTS) report minimal improvement or worsening of urinary function after radiotherapy. Patients with moderate to severe baseline LUTS experience improvement in general but continue to experience bothersome LUTS. The limited urodynamic data show a similar pattern in which peak flow rate declines and post‐void residual increases in the short term but return to baseline after long‐term follow‐up. These findings underscore the need for additional research to improve patient management and selection, and thereby improve genitourinary toxicity, function, and quality of life with contemporary radiotherapy techniques.
- 13 January 2026
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 18 (1) , e70046
Open AccessGenitourinary Toxicity, Function, and Quality of Life in Patients Undergoing Prostate Radiation Therapy—A Scoping Review
The effects of prostate radiotherapy (external beam radiation therapy (EBRT) and brachytherapy (BRT)) on urinary adverse events (UAEs), lower urinary tract function, and quality of life were examined in this scoping review. PubMed, Cochrane, and Embase (OVID) were used to identify relevant articles. We discuss the results of 23 studies. Included studies showed that UAEs are common after prostate radiation therapy. Across modalities, approximately one third experience acute events (Grade ≥ 2 median 36% for both EBRT and BRT), while one quarter experience late events (Grade ≥ 2 median 20% for EBRT and 26% for BRT). These estimates vary by UAE grading definitions and study designs. In the long term, patients with mild lower urinary tract symptoms (LUTS) report minimal improvement or worsening of urinary function after radiotherapy. Patients with moderate to severe baseline LUTS experience improvement in general but continue to experience bothersome LUTS. The limited urodynamic data show a similar pattern in which peak flow rate declines and post‐void residual increases in the short term but return to baseline after long‐term follow‐up. These findings underscore the need for additional research to improve patient management and selection, and thereby improve genitourinary toxicity, function, and quality of life with contemporary radiotherapy techniques.
- 12 December 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (5) , 951-960
What Evidence Do We Need From Objective and Subjective Outcomes in Order to Recommend Specific Operative Procedures for Men to Relieve BPO and Women With SUI? ICI‐RS 2025
Aim: Metrics used to evaluate meaningful clinical outcomes have long been a matter of controversy, particularly where there is no defined objective cure and patient‐reported metrics (PROMs) are utilised as objective measures of subjective phenomena. The ICI‐RS 2025 think tank discussed the relative merits of objective and subjective outcomes in clinical trials. Methods: A review of medical literature in four key areas; hard metrics versus PROMs assessment of Minimally Invasive Surgical Treatments for Bladder Outflow Obstruction, for Stress Urinary Incontinence, and their use in current registries and databases were debated. Limitations of trial design were highlighted and proposals for further reporting, steering groups and guidance panels suggested. Results: It is yet to be fully understood how objective data and PROMs weigh bias and variability. Longitudinal study for objective and subjective metrics is required. Qualitative study with benchmarking may allow future studies to allow patients to set their own goals and develop more nuanced, patient‐defined PROMs. Databases incorporating core metrics, specialist assessments and regression analysis may have utility to create composite algorithms into unified scoring systems. Artificial intelligence learning may be applied to large datasets. Conclusions: Both objective and subjective assessments have their limitations. A balanced approach, combining both may provide the most complete and accurate picture.
- 12 December 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (5) , 951-960
What Evidence Do We Need From Objective and Subjective Outcomes in Order to Recommend Specific Operative Procedures for Men to Relieve BPO and Women With SUI? ICI‐RS 2025
Aim: Metrics used to evaluate meaningful clinical outcomes have long been a matter of controversy, particularly where there is no defined objective cure and patient‐reported metrics (PROMs) are utilised as objective measures of subjective phenomena. The ICI‐RS 2025 think tank discussed the relative merits of objective and subjective outcomes in clinical trials. Methods: A review of medical literature in four key areas; hard metrics versus PROMs assessment of Minimally Invasive Surgical Treatments for Bladder Outflow Obstruction, for Stress Urinary Incontinence, and their use in current registries and databases were debated. Limitations of trial design were highlighted and proposals for further reporting, steering groups and guidance panels suggested. Results: It is yet to be fully understood how objective data and PROMs weigh bias and variability. Longitudinal study for objective and subjective metrics is required. Qualitative study with benchmarking may allow future studies to allow patients to set their own goals and develop more nuanced, patient‐defined PROMs. Databases incorporating core metrics, specialist assessments and regression analysis may have utility to create composite algorithms into unified scoring systems. Artificial intelligence learning may be applied to large datasets. Conclusions: Both objective and subjective assessments have their limitations. A balanced approach, combining both may provide the most complete and accurate picture.
- 5 December 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (5) , 914-921
Is There Adequate Evidence for Intracellular Bacteria Being a Significant Cause of rUTIs and Thereby Justifying Targeted Treatments Such as Bladder Fulguration or Intravesical Therapies? ICI‐RS 2025
Aims: Recurrent urinary tract infections are a common medical problem and current guidelines recommend both antibiotic and non‐antibiotic preventative treatments. However, for a significant proportion of patients with this condition these second‐line treatments are not effective. As a result, there has been recent focus on more targeted treatment such as intravesical instillations and bladder fulguration procedures. We aim to report discussions regarding these targeted treatments for recurrent urinary tract infections that took place at the International Consultation on Incontinence ‐ Research Society meeting in Bristol 2025. Methods: We undertook a think‐tank session during this multi‐disciplinary meeting specifically designated for discussion regarding targeted treatments for UTI prevention. We discussed the incidence and prevalence of recurrent UTIs in the general population and recognise that up to 25% of patients are not adequately treated with currently recommended preventive strategies. We also explored the increasing knowledge base surrounding the urinary microbiome and discussed the concept of chronic urinary tract infection. Finally we outlined the current evidence to support the use of the targeted treatments of intravesical instillation of both antibiotics and glycosaminoglycan (GAG) replacement compounds and the surgical procedure of bladder fulguration. This led to the generation of research ideas which hope to shape future UTI research within this topic area. Results: We describe the discussions that took place and document the important research questions that were generated during the International Consultation on Incontinence—Research Society meeting in Bristol 2025. Conclusions: Although the use of targeted treatments is becoming more widespread the evidence base is currently insufficient for strong guideline recommendation. This must be balanced against the significant need for second‐line treatments when current guideline recommended treatments are unsuccessful, particularly in the design of clinical pathways for patients with refractory recurrent UTIs.
- 5 December 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (5) , 914-921
Is There Adequate Evidence for Intracellular Bacteria Being a Significant Cause of rUTIs and Thereby Justifying Targeted Treatments Such as Bladder Fulguration or Intravesical Therapies? ICI‐RS 2025
Aims: Recurrent urinary tract infections are a common medical problem and current guidelines recommend both antibiotic and non‐antibiotic preventative treatments. However, for a significant proportion of patients with this condition these second‐line treatments are not effective. As a result, there has been recent focus on more targeted treatment such as intravesical instillations and bladder fulguration procedures. We aim to report discussions regarding these targeted treatments for recurrent urinary tract infections that took place at the International Consultation on Incontinence ‐ Research Society meeting in Bristol 2025. Methods: We undertook a think‐tank session during this multi‐disciplinary meeting specifically designated for discussion regarding targeted treatments for UTI prevention. We discussed the incidence and prevalence of recurrent UTIs in the general population and recognise that up to 25% of patients are not adequately treated with currently recommended preventive strategies. We also explored the increasing knowledge base surrounding the urinary microbiome and discussed the concept of chronic urinary tract infection. Finally we outlined the current evidence to support the use of the targeted treatments of intravesical instillation of both antibiotics and glycosaminoglycan (GAG) replacement compounds and the surgical procedure of bladder fulguration. This led to the generation of research ideas which hope to shape future UTI research within this topic area. Results: We describe the discussions that took place and document the important research questions that were generated during the International Consultation on Incontinence—Research Society meeting in Bristol 2025. Conclusions: Although the use of targeted treatments is becoming more widespread the evidence base is currently insufficient for strong guideline recommendation. This must be balanced against the significant need for second‐line treatments when current guideline recommended treatments are unsuccessful, particularly in the design of clinical pathways for patients with refractory recurrent UTIs.
- 2 December 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (5) , 879-885
How Could the Proposed International Continence Society (ICS) Global Urodynamics Data Repository (GUDRep) Demonstrate the Clinical Role and Cost Effectiveness of Urodynamics in Individual Patients? ICI‐RS 2025
Introduction: The management and interpretation of big data appears to be an increasingly attractive but challenging issue in functional urology. The International Continence Society (ICS) Global Urodynamics (UDS) Data Repository (GUDRep) project aims to record and analyse UDS data to share research and clinical information about UDS. Objectives: The aim of this Think Tank was to identify the main research questions and critical issues related to the GUDRep project. Methods: This article reports and summarises the discussions on the GUDRep from the 2025 meeting of the International Consultation on Incontinence‐Research Society (ICI‐RS). Results and Conclusions: Several research questions on the GUDRep project need to be considered, including both issues/barriers in building the Repository and economic, clinical and research advantages which could potentially be obtained by the GUDRep itself.
- 2 December 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (5) , 879-885
How Could the Proposed International Continence Society (ICS) Global Urodynamics Data Repository (GUDRep) Demonstrate the Clinical Role and Cost Effectiveness of Urodynamics in Individual Patients? ICI‐RS 2025
Introduction: The management and interpretation of big data appears to be an increasingly attractive but challenging issue in functional urology. The International Continence Society (ICS) Global Urodynamics (UDS) Data Repository (GUDRep) project aims to record and analyse UDS data to share research and clinical information about UDS. Objectives: The aim of this Think Tank was to identify the main research questions and critical issues related to the GUDRep project. Methods: This article reports and summarises the discussions on the GUDRep from the 2025 meeting of the International Consultation on Incontinence‐Research Society (ICI‐RS). Results and Conclusions: Several research questions on the GUDRep project need to be considered, including both issues/barriers in building the Repository and economic, clinical and research advantages which could potentially be obtained by the GUDRep itself.
- Open Access
- 12 November 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (5) , 922-928
What Is Required for AI to Improve the Assessment and Treatment of Patients With Lower Urinary Tract Dysfunction? ICI‐RS 2025
Introduction: Artificial intelligence (AI) is poised to improve the diagnosis and management of lower urinary tract dysfunction (LUTD). Its effective deployment requires prioritization, regulatory oversight, rigorous validation, and clinician and patient engagement. Methods: The Think Tank at the International Consultation on Incontinence—Research Society (ICI‐RS) 2025 evaluated key considerations for successful AI implementation into LUTD clinical care. The topics included clinical triage framework, regulatory and legal principles, levels of evidence required for validation, and clinician and patient engagement to guide development. The group developed a narrative of the pressing matters related to AI implementation and a list of proposed research questions, which, when addressed, will help shape the future of the field. Results: LUTD topics that should be prioritized for AI implementation include high‐burden conditions with high unmet need such as neurogenic LUTD, bladder outlet obstruction, and overactive bladder. Regulatory frameworks such as the EU AI Act and the U.S. “Software as a Medical Device” and its associated guidance promote safety, transparency, and accountability. AI solutions should be as rigorously evaluated as other clinical devices or drug agents. Patient and clinician engagement are paramount to ensure innovation aligns with the pressing needs of patients and clinicians. Conclusions: AI's integration into LUTD care requires cross‐disciplinary collaboration, prospective validation, and legal and ethical frameworks. AI must be developed and implemented with a strong focus on transparency, trust, and patient‐centered care. Clinical Trial Registration: This study is not a clinical trial and thus does not warrant registration as such.
- 12 November 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (5) , 922-928
Open AccessWhat Is Required for AI to Improve the Assessment and Treatment of Patients With Lower Urinary Tract Dysfunction? ICI‐RS 2025
Introduction: Artificial intelligence (AI) is poised to improve the diagnosis and management of lower urinary tract dysfunction (LUTD). Its effective deployment requires prioritization, regulatory oversight, rigorous validation, and clinician and patient engagement. Methods: The Think Tank at the International Consultation on Incontinence—Research Society (ICI‐RS) 2025 evaluated key considerations for successful AI implementation into LUTD clinical care. The topics included clinical triage framework, regulatory and legal principles, levels of evidence required for validation, and clinician and patient engagement to guide development. The group developed a narrative of the pressing matters related to AI implementation and a list of proposed research questions, which, when addressed, will help shape the future of the field. Results: LUTD topics that should be prioritized for AI implementation include high‐burden conditions with high unmet need such as neurogenic LUTD, bladder outlet obstruction, and overactive bladder. Regulatory frameworks such as the EU AI Act and the U.S. “Software as a Medical Device” and its associated guidance promote safety, transparency, and accountability. AI solutions should be as rigorously evaluated as other clinical devices or drug agents. Patient and clinician engagement are paramount to ensure innovation aligns with the pressing needs of patients and clinicians. Conclusions: AI's integration into LUTD care requires cross‐disciplinary collaboration, prospective validation, and legal and ethical frameworks. AI must be developed and implemented with a strong focus on transparency, trust, and patient‐centered care. Clinical Trial Registration: This study is not a clinical trial and thus does not warrant registration as such.
- Open Access
- 15 June 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 44 (6) , 1231-1237
Envisioning the Future of AI in Urodynamics: Exploratory Interviews With Experts
Background: Urodynamics monitors various parameters while the urinary bladder fills and empties, to diagnose functional or anatomic disorders of the lower urinary tract. It is an invasive and complex test with technical challenges, and it needs rigorous quality assessment and training of clinicians to avoid misdiagnosis. Applying AI to urodynamic pattern recognition and noisy data signals seems promising.Aim: To understand desirable and appropriate applications, this study aims to explore the envisioned future of AI in urodynamics according to experts in AI and/or urodynamics.Method: Ten semi‐structured interviews were conducted to explore expectations, trust and possibilities of AI in urodynamics. Content analysis with an inductive approach was performed on all data.Results: The analysis resulted in seven overarching themes: difficulties with urodynamics, quality of urodynamics, AI will be supportive, development and training of AI systems, desirable outcomes, challenges, and envisioning the future of AI in urodynamics.Discussion and Conclusion: In the vision of experts, urodynamics practices will change with the introduction of AI. In the beginning, clinicians will probably desire to check AI‐made outcomes of UDS tests to gain trust the system. After experiencing the value of these systems, clinicians might let the system independently provide suggested UDS analyses, and they will use more of their time to spend on their patients.
- 15 June 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 44 (6) , 1231-1237
Open AccessEnvisioning the Future of AI in Urodynamics: Exploratory Interviews With Experts
Background: Urodynamics monitors various parameters while the urinary bladder fills and empties, to diagnose functional or anatomic disorders of the lower urinary tract. It is an invasive and complex test with technical challenges, and it needs rigorous quality assessment and training of clinicians to avoid misdiagnosis. Applying AI to urodynamic pattern recognition and noisy data signals seems promising.Aim: To understand desirable and appropriate applications, this study aims to explore the envisioned future of AI in urodynamics according to experts in AI and/or urodynamics.Method: Ten semi‐structured interviews were conducted to explore expectations, trust and possibilities of AI in urodynamics. Content analysis with an inductive approach was performed on all data.Results: The analysis resulted in seven overarching themes: difficulties with urodynamics, quality of urodynamics, AI will be supportive, development and training of AI systems, desirable outcomes, challenges, and envisioning the future of AI in urodynamics.Discussion and Conclusion: In the vision of experts, urodynamics practices will change with the introduction of AI. In the beginning, clinicians will probably desire to check AI‐made outcomes of UDS tests to gain trust the system. After experiencing the value of these systems, clinicians might let the system independently provide suggested UDS analyses, and they will use more of their time to spend on their patients.
- Open Access
- 15 February 2025
- Published by Elsevier in Continence
- Vol. 13
Bladder outlet obstruction surgery in patients undergoing radiation therapy for prostate cancer: Adverse events, functional outcomes and quality of life — A scoping review
- 15 February 2025
- Published by Elsevier in Continence
- Vol. 13
Open AccessBladder outlet obstruction surgery in patients undergoing radiation therapy for prostate cancer: Adverse events, functional outcomes and quality of life — A scoping review
- Open Access
- 19 November 2024
- Published by Wiley in Neurourology and Urodynamics
- Vol. 44 (3) , 683-690
What Is Needed to Determine and Potentially Improve the Clinical Effectiveness and Cost‐Effectiveness of Robot‐Assisted Reconstructive Urinary Tract and Pelvic Floor Surgery?—ICI‐RS 2024
Introduction: Robot‐assisted (RA) surgery has many advantages for urinary tract and pelvic floor reconstruction (UTPFR) but its application is only slowly increasing. Studies are limited in number, patients and follow‐up duration. The low‐volume high‐complexity nature of UTPFR warrants specific research to evaluate the potential role of the RA approach.Methods: During its 2024 meeting in Bristol, the International Consultation on Incontinence‐Research Society (ICI‐RS) reviewed the current literature on RA UTPFR. Priority research questions and strategies were explored in a proposal.Results: Four different topics were discussed. (1) Large multicentre prospective studies on RA UTPFR are needed to evaluate clinical effectiveness and safety. The RA approach needs to be prioritized in specific procedures and patients, to first improve patient care where gains are highest. (2) Models for cost‐utility analysis for RA UTPFR are needed to (re)direct limited resources as efficiently as possible in a quickly changing technological field. (3) A modular curriculum for training UTPFR surgeons to become RA certified needs to be developed, to allow valid interpretation and comparison of outcomes. (4) Technological improvements to address tissue handling, accessibility, efficiency and sustainability are needed. Digitalization can be a gamechanger for RA UTPFR through telesurgery (training and expertize coverage), augmented reality and artificial intelligence providing intra‐operative assistance, assessment and feedback.Conclusions: The proposal discussed the need for studies on clinical and cost effectiveness, safety, and training curriculum development for RA UTPFR. Recent technological developments hold great promise for RA UTPFR. High‐priority research questions were identified.
- 19 November 2024
- Published by Wiley in Neurourology and Urodynamics
- Vol. 44 (3) , 683-690
Open AccessWhat Is Needed to Determine and Potentially Improve the Clinical Effectiveness and Cost‐Effectiveness of Robot‐Assisted Reconstructive Urinary Tract and Pelvic Floor Surgery?—ICI‐RS 2024
Introduction: Robot‐assisted (RA) surgery has many advantages for urinary tract and pelvic floor reconstruction (UTPFR) but its application is only slowly increasing. Studies are limited in number, patients and follow‐up duration. The low‐volume high‐complexity nature of UTPFR warrants specific research to evaluate the potential role of the RA approach.Methods: During its 2024 meeting in Bristol, the International Consultation on Incontinence‐Research Society (ICI‐RS) reviewed the current literature on RA UTPFR. Priority research questions and strategies were explored in a proposal.Results: Four different topics were discussed. (1) Large multicentre prospective studies on RA UTPFR are needed to evaluate clinical effectiveness and safety. The RA approach needs to be prioritized in specific procedures and patients, to first improve patient care where gains are highest. (2) Models for cost‐utility analysis for RA UTPFR are needed to (re)direct limited resources as efficiently as possible in a quickly changing technological field. (3) A modular curriculum for training UTPFR surgeons to become RA certified needs to be developed, to allow valid interpretation and comparison of outcomes. (4) Technological improvements to address tissue handling, accessibility, efficiency and sustainability are needed. Digitalization can be a gamechanger for RA UTPFR through telesurgery (training and expertize coverage), augmented reality and artificial intelligence providing intra‐operative assistance, assessment and feedback.Conclusions: The proposal discussed the need for studies on clinical and cost effectiveness, safety, and training curriculum development for RA UTPFR. Recent technological developments hold great promise for RA UTPFR. High‐priority research questions were identified.
- Open Access
- 21 January 2020
- Published by Wiley in Neurourology and Urodynamics
- Vol. 39 (S3) , S30-S35
Can multicentre urodynamic studies provide high quality evidence for the clinical effectiveness of urodynamics? ICI‐RS 2019
Aims: Lower urinary tract (LUT) function can be investigated by urodynamic studies (UDS) to establish underlying functional abnormalities in the LUT. A multicentre registry could present an opportunity to improve the scientific evidence base for UDS. During the International Consultation on Incontinence Research Society (ICI‐RS) meeting in Bristol, United Kingdom 2019, an expert panel discussed the potential of a multicentre urodynamic registry to improve the quality of urodynamic output.Methods: the potential importance of a multicentre urodynamic registry, parameter inclusion, quality control, and pitfalls during a registry roll‐out were reviewed and discussed.Results and Conclusions: The clinical utility, evaluation, and effectiveness of UDS remain poorly defined due to a lack of high quality evidence and large study populations. Therefore, the ICI‐RS proposes formation of a urodynamic panel for future roll‐out of a registry. The inclusion of basic parameters was discussed and the essential parameters were defined as well as the potential pitfalls of a registry roll‐out. The discussion and recommendations in this paper form the base for future urodynamic registry development.
- 21 January 2020
- Published by Wiley in Neurourology and Urodynamics
- Vol. 39 (S3) , S30-S35
Open AccessCan multicentre urodynamic studies provide high quality evidence for the clinical effectiveness of urodynamics? ICI‐RS 2019
Aims: Lower urinary tract (LUT) function can be investigated by urodynamic studies (UDS) to establish underlying functional abnormalities in the LUT. A multicentre registry could present an opportunity to improve the scientific evidence base for UDS. During the International Consultation on Incontinence Research Society (ICI‐RS) meeting in Bristol, United Kingdom 2019, an expert panel discussed the potential of a multicentre urodynamic registry to improve the quality of urodynamic output.Methods: the potential importance of a multicentre urodynamic registry, parameter inclusion, quality control, and pitfalls during a registry roll‐out were reviewed and discussed.Results and Conclusions: The clinical utility, evaluation, and effectiveness of UDS remain poorly defined due to a lack of high quality evidence and large study populations. Therefore, the ICI‐RS proposes formation of a urodynamic panel for future roll‐out of a registry. The inclusion of basic parameters was discussed and the essential parameters were defined as well as the potential pitfalls of a registry roll‐out. The discussion and recommendations in this paper form the base for future urodynamic registry development.
- 19 December 2019
- Published by Wiley in Neurourology and Urodynamics
- Vol. 39 (S3) , S43-S49
Can we improve our diagnosis of impaired detrusor contractility in women? An ICI‐RS 2019 proposal
Introduction: Widely accepted consensus terminology and calculations of detrusor contractility in females do not exist but may be useful. We report the output of a proposal session at the International Consultation on Incontinence Research Society meeting 2019, addressing the title topic.Methods: Three formal presentations and a lively discussion addressed several questions including: which is the optimal cutoff value of female bladder voiding efficiency during uroflow to suspect obstruction or detrusor underactivity? Is there a definition of pure underactive and pure obstructed voiding in females? Is there a place to distinguish those relatively obstructed from those relatively underactive females especially in those cases of equivocal obstruction? Current measures of contractility were reviewed for their usefulness in women.Results: No recommendation for a specific index or calculation can be made based on current knowledge. “Contractility” may be context‐dependent regarding clinical care, clinical prognostication, and physiologic research.Conclusions: This group proposes that context‐sensitive definitions of “Contractility” deserve attention by international leadership. Cooperative clinical and physiologic expertise will be needed to achieve this goal. Following initial recommendations based on expert opinion, the development of final definitions and measures of contractility should be iterative, based upon validation studies to be considered as part of the definitional process.
- 19 December 2019
- Published by Wiley in Neurourology and Urodynamics
- Vol. 39 (S3) , S43-S49
Can we improve our diagnosis of impaired detrusor contractility in women? An ICI‐RS 2019 proposal
Introduction: Widely accepted consensus terminology and calculations of detrusor contractility in females do not exist but may be useful. We report the output of a proposal session at the International Consultation on Incontinence Research Society meeting 2019, addressing the title topic.Methods: Three formal presentations and a lively discussion addressed several questions including: which is the optimal cutoff value of female bladder voiding efficiency during uroflow to suspect obstruction or detrusor underactivity? Is there a definition of pure underactive and pure obstructed voiding in females? Is there a place to distinguish those relatively obstructed from those relatively underactive females especially in those cases of equivocal obstruction? Current measures of contractility were reviewed for their usefulness in women.Results: No recommendation for a specific index or calculation can be made based on current knowledge. “Contractility” may be context‐dependent regarding clinical care, clinical prognostication, and physiologic research.Conclusions: This group proposes that context‐sensitive definitions of “Contractility” deserve attention by international leadership. Cooperative clinical and physiologic expertise will be needed to achieve this goal. Following initial recommendations based on expert opinion, the development of final definitions and measures of contractility should be iterative, based upon validation studies to be considered as part of the definitional process.